Invention Grant
- Patent Title: Use of VAP-1 inhibitors for treating fibrotic conditions
-
Application No.: US15711828Application Date: 2017-09-21
-
Publication No.: US10576148B2Publication Date: 2020-03-03
- Inventor: Christopher Weston , Lee Charles Claridge , David Adams , David Smith , Nina Westerlund , Marjo Pihlavisto , Thua Österman
- Applicant: BIOTIE THERAPIES CORP. , THE UNIVERSITY OF BIRMINGHAM
- Applicant Address: FI Turku GB Birmingham
- Assignee: BIOTIE THERAPIES CORP.,THE UNIVERSITY OF BIRMINGHAM
- Current Assignee: BIOTIE THERAPIES CORP.,THE UNIVERSITY OF BIRMINGHAM
- Current Assignee Address: FI Turku GB Birmingham
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/00 ; C07K16/40 ; A61K31/137 ; A61K31/185 ; A61K39/00 ; G01N33/68 ; G01N33/573
Abstract:
The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.
Public/Granted literature
- US20180071388A1 USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS Public/Granted day:2018-03-15
Information query
